a month ago
LLY
AnalystsChris SchottChris Schott's Stock Forecasts
AnalystsChris Schott
Analyst Ranking
Top 20%
#901 out of 4554 analysts
Average Return
+6.56%
Win Rate
57%25 out of 44
Risk vs Reward
Poor
Good
Chris Schott's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Eli Lilly & CoLLY | +88.44% | $395.86 | $745.95 | 2023-04-27 - 2024-04-18 | Strong Buy |
Eli Lilly & CoLLY | +74.11% | $428.44 | $745.95 | 2023-05-03 - 2024-04-18 | Strong Buy |
Kala Bio IncKALA | +73.24% | $205.50 | $356.00 | 2019-11-07 - 2020-11-06 | Strong Buy |
Heska CorpHSKA | +66.51% | $72.06 | $119.99 | 2022-10-16 - 2023-06-12 | Strong Buy |
Eli Lilly & CoLLY | +62.80% | $146.12 | $237.88 | 2020-10-15 - 2021-10-15 | Strong Buy |
Chris Schott Analyst Color
Get additional color on Chris Schott's coverage of popular stocks
6 months ago
PFE
8 months ago
LLY
9 months ago
LLY
a year ago
LLY
a year ago
LLY
Chris Schott's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Biogen IncBIIB | 2 | Hold | $240.00 | +25.97% | Maintains | 8 days ago |
Eli Lilly & CoLLY | 9 | Strong Buy | $850.00 | +13.95% | Maintains | a month ago |
Teva Pharmaceutical Industries LtdTEVA | 4 | Hold | $14.00 | +9.55% | Upgrades | a month ago |
Perrigo Co PLCPRGO | 4 | Strong Buy | $41.00 | +36.94% | Maintains | 2 months ago |
Royalty Pharma PLCRPRX | 4 | Strong Buy | $42.00 | +50.59% | Maintains | 2 months ago |
Idexx Laboratories IncIDXX | 6 | Strong Buy | $630.00 | +31.86% | Maintains | 2 months ago |
Amgen IncAMGN | 1 | Hold | $270.00 | +2.76% | Reinstates | 6 months ago |
Pfizer IncPFE | 3 | Hold | $34.00 | +33.91% | Maintains | 6 months ago |
Regeneron Pharmaceuticals IncREGN | 2 | Strong Buy | $950.00 | N/A | Maintains | a year ago |
Merck & Co IncMRK | 4 | Strong Buy | $125.00 | N/A | Maintains | a year ago |
Viatris IncVTRS | 2 | Hold | $14.00 | N/A | Maintains | a year ago |
Coherus Biosciences IncCHRS | 2 | Hold | $11.00 | N/A | Maintains | a year ago |
Eqrx IncEQRX | 2 | Strong Sell | N/A | N/A | Downgrades | a year ago |
Elanco Animal Health IncELAN | 3 | Hold | $20.00 | N/A | Maintains | 2 years ago |
Heska CorpHSKA | 2 | Strong Buy | $150.00 | N/A | Maintains | 2 years ago |
Zoetis IncZTS | 1 | Strong Buy | $225.00 | N/A | Maintains | 2 years ago |
Gilead Sciences IncGILD | 1 | Strong Buy | $80.00 | N/A | Upgrades | 2 years ago |
Bausch Health Companies IncBHC | 3 | Hold | N/A | N/A | Downgrades | 2 years ago |
Organon & CoOGN | 1 | Hold | $38.00 | N/A | Initiates Coverage On | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Strong Buy | $110.00 | N/A | Initiates Coverage On | 4 years ago |
Kala Bio IncKALA | 4 | Strong Buy | $950.00 | N/A | Maintains | 4 years ago |
Endo International PLCENDPQ | 2 | Hold | $10.00 | N/A | Maintains | 5 years ago |
Pacira Biosciences IncPCRX | 2 | Hold | $50.00 | N/A | Maintains | 5 years ago |
Bristol Myers Squibb CoBMY | 1 | Strong Buy | $74.00 | N/A | Maintains | 6 years ago |
Therapeuticsmd IncTXMD | 1 | Strong Buy | $550.00 | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.